echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > BMC Gastroenterology: The expression level of Cyr61 is related to the clinical course of patients with Crohn's disease

    BMC Gastroenterology: The expression level of Cyr61 is related to the clinical course of patients with Crohn's disease

    • Last Update: 2021-03-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Crohn's disease (CD) is a chronic idiopathic intestinal inflammation, it will affect the medsci.


     Crohn's disease (CD) is a chronic idiopathic intestinal inflammation, it will affect the medsci.


     

     

     

    The researchers screened endoscopic samples of 83 CD patients and 372 control patients from the case database, and compared the expression of Cyr61 in the mucosa of the patients through immunohistochemistry (IHC).


    immunity

     

     

     

    The average IHC score of Cyr61 expression in CD patients was significantly higher than that in the control group (86.


     

     

     

    The mucosal expression of Cyr61 in CD patients is negatively correlated with the clinical course.


    The mucosal expression of Cyr61 in CD patients is negatively correlated with the clinical course.


     

     

    Original source:

    Su-Mi Lee.


    biomedcentral.
    com/articles/10.
    1186/s12876-021-01713-9" target="_blank" rel="noopener">Expression of Cyr61 is associated with clinical course in patients with Crohn's disease.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.